- Home
- REVB vs CREG Comparison
REVB vs CREG Comparison
Compare REVB & CREG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REVB
- CREG
- Stock Information
- Founded
- REVB 2020
- CREG N/A
- Country
- REVB United States
- CREG China
- Employees
- REVB N/A
- CREG N/A
- Industry
- REVB Biotechnology: Pharmaceutical Preparations
- CREG Power Generation
- Sector
- REVB Health Care
- CREG Utilities
- Exchange
- REVB Nasdaq
- CREG Nasdaq
- Market Cap
- REVB 4.4M
- CREG 4.7M
- IPO Year
- REVB N/A
- CREG N/A
- Fundamental
- Price
- REVB $1.55
- CREG $1.60
- Analyst Decision
- REVB
- CREG
- Analyst Count
- REVB 0
- CREG 0
- Target Price
- REVB N/A
- CREG N/A
- AVG Volume (30 Days)
- REVB 890.8K
- CREG 258.2K
- Earning Date
- REVB 11-07-2025
- CREG 11-07-2025
- Dividend Yield
- REVB N/A
- CREG N/A
- EPS Growth
- REVB N/A
- CREG N/A
- EPS
- REVB N/A
- CREG N/A
- Revenue
- REVB N/A
- CREG $82,839.00
- Revenue This Year
- REVB N/A
- CREG N/A
- Revenue Next Year
- REVB N/A
- CREG N/A
- P/E Ratio
- REVB N/A
- CREG N/A
- Revenue Growth
- REVB N/A
- CREG N/A
- 52 Week Low
- REVB $1.50
- CREG $1.11
- 52 Week High
- REVB $60.48
- CREG $14.70
- Technical
- Relative Strength Index (RSI)
- REVB 25.99
- CREG 50.19
- Support Level
- REVB $1.50
- CREG $1.47
- Resistance Level
- REVB $2.90
- CREG $1.67
- Average True Range (ATR)
- REVB 0.20
- CREG 0.17
- MACD
- REVB -0.13
- CREG 0.04
- Stochastic Oscillator
- REVB 3.57
- CREG 53.57
About REVB Revelation Biosciences Inc.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
About CREG Smart Powerr Corp.
Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.